$0.189
+0.022 (+11.90%)At close
EDVA Profitability and Margins
Evaluating the bottom line, Endovia Health Sciences, Inc. maintains a gross margin of 43.75%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -70699.24%, while the net margin is -98126.49%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively EDVA converts its operational activities into shareholder value.
EDVA Comparative Benchmarking
In the context of the broader market, EDVA competes directly with industry leaders such as IVF and OGCP. With a market capitalization of $2.09M, it holds a significant position in the sector. When comparing efficiency, EDVA's gross margin of 43.75% stands against IVF's 28.37% and OGCP's N/A. Such benchmarking helps identify whether Endovia Health Sciences, Inc. is trading at a premium or discount relative to its financial performance.
Splash Beverage Group, Inc. Financial Performance
The company has shown a gross margin improvement to 43.75% in Q1 2026, but still reports significant net losses, with a net income of -2.20 per share.
Financials
Related articles
- CPI Report and the Stock Market: How to Read October 2026 Inflation Data Before the Fed DecidesOctober 2026 CPI lands Nov 10 with no year-over-year number and Fed hike odds near 80%. Learn how to read CPI, which stocks react, and how to plan for it.
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.